Stockscreener 앱 받기
52.72
5.45%
2.7243
Terns Pharmaceuticals Inc 주식(TERN)의 최신 뉴스
Unsurging Financial Prospects for Terns Pharmaceuticals Inc. - timothysykes.com
Shareholder Alert: The Ademi Firm investigates whether Terns Pharmaceuticals Inc. is obtaining a Fair Price for Public Shareholders - PR Newswire
Merck buying Terns in $6.7B deal to bolster its cancer portfolio before key Keytruda patent expires - WRAL
MRK: Acquisition brings TERN-701, a high-potential CML therapy, into the hematology portfolio - TradingView
Merck to Acquire HBM Portfolio Company Terns Pharmaceuticals for USD 6.7 Billion - marketscreener.com
Merck To Buy Terns, ‘Unprecedented’ Leukemia Drug for $6.7B as Keytruda Cliff Looms - BioSpace
Merck makes bold $5.7 billion bet on Terns Pharmaceuticals - Rolling Out
Why Merck's $6.7 Billion Deal Could Start A Fight - Investor's Business Daily
Merck acquires Terns Pharmaceuticals stock for $6.7 billion - Investing.com
Merck to acquire Terns Pharmaceuticals in US$6.7 bil deal - The Edge Singapore
Merck to buy Terns Pharmaceuticals for $6.7bn - Sharecast.com
Merck (MRK.US) Plans to Acquire Biotech Firm Terns Pharmaceuticals (TERN.US) for USD6.7 Billion - AASTOCKS.com
MSD buys biotech Terns Pharmaceuticals for nearly USD 6bn - medwatch.com
Merck to Acquire Terns Pharmaceuticals in $6.7 Billion Deal - marketscreener.com
Merck (MRK) to Acquire Terns Pharmaceuticals for $6.7 Billion - GuruFocus
Merck (MRK) to Acquire Terns Pharmaceuticals (TERN) for $6.7 Bil - GuruFocus
Terns Pharmaceuticals to Be Acquired by Merck - TipRanks
Merck Seals $6.7B Deal to Acquire Terns Pharmaceuticals and Boosts Oncology Pipeline - StockInvest.us
Q&A: Why Is Merck Spending Nearly $6 Billion to Acquire Terns Pharmaceuticals? - citybiz
Merck (MRK) Seals $6.7B Deal for Terns Pharma (TERN) in Latest Cancer Portfolio Expansion - Blockonomi
Merck to Launch Tender Offer for Terns Pharmaceuticals (NASDAQ: TERN) - Stock Titan
Merck (MRK) to Acquire Terns Pharmaceuticals in $6.7 Billion Dea - GuruFocus
Merck (MRK) Announces Acquisition of Terns Pharmaceuticals - GuruFocus
Terns Pharmaceuticals to Be Acquired by Merck in $53-Per-Share Tender Offer and Merger - TradingView
Merck (MRK) Stock Acquires Terns Pharma (TERN) for $6.7 Billion to Bolster Cancer Pipeline - CoinCentral
Merck to buy Terns Pharmaceuticals (NASDAQ: TERN) in $6.7B cash deal - Stock Titan
Merck to buy Terns Pharmaceuticals for $6.7 billion to boost cancer pipeline - CNBC
Merck To Acquire Terns In $6.7 Billion Deal – Signaling Fresh Push In Competitive Cancer Drug Race - Stocktwits
The merger and acquisition deal between Merck and Terns Pharmaceuticals, Inc. has received official approval from the boards of directors of both parties. - Bitget
Merck to acquire Terns Pharmaceuticals for $53 per share in cash - MSN
Merck to buy Terns for $6.7 billion - breakingthenews.net
Merck Close to $6 Billion Deal to Acquire Terns Pharma, FT Says - Meyka
Merck to Acquire Terns Pharmaceuticals, Inc., Expanding Its Hematology Pipeline With TERN-701, a Novel Candidate for Chronic Myeloid Leukemia (CML) - Bitget
Merck to buy oncology firm Terns Pharmaceuticals in $6.7 billion deal - Investing.com Australia
Merck to Acquire Terns Pharmaceuticals, Inc., Expanding Its Hematology Pipeline With TERN-701, a Novel Candidate for Chronic Myeloid Leukemia (CML) - Benzinga
Merck (MRK) Nears Acquisition Deal with Terns Pharmaceuticals - GuruFocus
MSD rumoured to be nearing $6bn play for Terns Pharma - pharmaphorum
Merck Nears $6 Billion Deal To Buy Terns Pharma: Report - Benzinga
MSD close to USD 6bn acquisition of Terns Pharmaceuticals - medwatch.com
Merck Nears Deal to Buy Terns Pharmaceuticals - Bloomberg
Why Terns Pharmaceuticals Stock Is Suddenly Sinking - TipRanks
Merck Nears $6 Billion Deal to Acquire Terns Pharma - marketscreener.com
SLS Vs. TERN: Which Pharma Stock Has More Upside As Merck Eyes $6B Cancer Bet Ahead Of Keytruda Patent Cliff - Stocktwits
Merck nears $6 bln deal for Terns Pharma, FT reports By Investing.com - Investing.com Canada
Merck (MRK) Nears $6 Billion Acquisition of Terns Pharmaceuticals (TERN) - GuruFocus
Terns Pharma shares surge on reported $6B acquisition talks with Merck (MRK:NYSE) - Seeking Alpha
Merck nears $6 bln deal for Terns Pharma, FT reports - Investing.com
Merck’s Strategic Move with Terns Pharma: A Bold Oncology Investment in a Competitive Market - Bitget
Merck nears $6 billion acquisition of Terns Pharma to boost cancer portfolio, FT reports - marketscreener.com
According to insiders, merger negotiations between Merck (MRK) and Terns Pharmaceuticals, Inc. (TERN) have entered a critical stage. - Bitget
Merck nears $6 billion all-cash deal to buy Terns Pharma, FT reports - marketscreener.com
Merck to acquire Terns Pharmaceuticals for $6.7B to bolster oncology pipeline - grafa.com
Acorn Capital Sells $5.2M in Terns Pharma Shares, Remains Top Holding | 2026 UpdateNews and Statistics - IndexBox
Terns Pharmaceuticals (NASDAQ:TERN) Lowered to "Sell" Rating by Wall Street Zen - MarketBeat
Terns Pharmaceuticals (NASDAQ:TERN) Sets New 12-Month HighShould You Buy? - MarketBeat
TERN Stock Chart | TERNS PHARMACEUTICALS INC (NASDAQ:TERN) - ChartMill
Terns Pharmaceuticals stock hits all-time high at 48.27 USD By Investing.com - Investing.com India
Aug PreEarnings: What is the target price for Terns Pharmaceuticals Inc stockShare Buyback & Stepwise Trade Execution Plans - baoquankhu1.vn
Terns Pharmaceuticals stock hits all-time high at 48.27 USD - Investing.com
How Vestal Point’s Big Bet On TERN-701 At Terns Pharmaceuticals (TERN) Has Changed Its Investment Story - Yahoo Finance
Aug Setups: What is the target price for Terns Pharmaceuticals Inc stockWall Street Watch & Daily Stock Momentum Reports - baoquankhu1.vn
Superstring Capital Reduces Terns Pharmaceuticals Holding in Late 2025News and Statistics - IndexBox
Terns Pharmaceuticals CEO Burroughs sells $681k in stock By Investing.com - Investing.com Canada
Terns Pharmaceuticals CEO Burroughs sells $681k in stock - Investing.com
Amy Burroughs Sells 14,583 Shares of Terns Pharmaceuticals (NASDAQ:TERN) Stock - MarketBeat
Terns Pharmaceuticals CEO Amy L. Burroughs Sells Shares - TradingView
1.56%
자본화:
|
볼륨(24시간):